Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma

​ Conditions: DLBCL; CLL; FL; MCL; WM; MZL

Interventions: Drug: BAFF-R CAR-T

Sponsors: Institute of Hematology & Blood Diseases Hospital, China; Hebei Taihe Chunyu Biotechnology Co., Ltd

Not yet recruiting Conditions: DLBCL; CLL; FL; MCL; WM; MZL
Interventions: Drug: BAFF-R CAR-T
Sponsors: Institute of Hematology & Blood Diseases Hospital, China; Hebei Taihe Chunyu Biotechnology Co., Ltd
Not yet recruiting